Laboratory-based, 2-year surveillance of pediatric parapneumonic pneumococcal empyema following heptavalent pneumococcal conjugate vaccine universal vaccination in madrid

Pediatric Infectious Disease Journal

Volumn 30, Issue 6, 2011, Pages 471-474

  Picazo, Juan ^a   Ruiz Contreras, Jesus ^b   Casado Flores, Juan ^c   Negreira, Sagrario ^b   Del Castillo, Fernando ^d   Hernández Sampelayo, Teresa ^e   Bueno, Mercedes ^f   Calvo, Cristina ^g   Ríos, Esther ^a   Méndez, Cristina ^h  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^d HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^e HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^f HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^g HOSPITAL SEVERO OCHOA   (Spain)

^h PFIZER INC   (United States)

Author keywords

empyema; nonvaccine serotypes; PCR; PCV7; surveillance

Indexed keywords

CEFOTAXIME; ERYTHROMYCIN; PENICILLIN G; PNEUMOCOCCUS VACCINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CHILD; DISEASE SURVEILLANCE; FEMALE; HOSPITALIZATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PARAPNEUMONIC PNEUMOCOCCAL EMPYEMA; PLEURA EMPYEMA; PLEURA FLUID; PNEUMOCOCCAL INFECTION; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SEROTYPING; SPAIN; VACCINATION;

EID: 79957993546     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31820a418a     Document Type: Article

References (27)

1. Byington CL, Hulten KG, Ampofo K, et al. Molecular epidemiology of pediatric pneumococcal empyema 2001-2007. J Clin Microbiol. 2010;48: 520-525.
2. Byington CL, Korgenski K, Daly J, et al. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr Infect Dis J. 2006;25:250-254. (Pubitemid 43379067)
3. Calbo E, Diaz A, Canadell E, et al. Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococcal conjugate vaccine. Clin Microbiol Infect. 2006;12:867-872. (Pubitemid 44151286)
4. Eastham KM, Freeman R, Kearns AM, et al. Clinical features, aetiology and outcome of empyema in children in the north east of England. Thorax. 2004;59:522-525. (Pubitemid 38797527)
5. Muñoz-Almagro C, Jordan I, Gene A, et al. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. Clin Infect Dis. 2008;46:174-182. (Pubitemid 351269154)
6. Obando I, Muñoz-Almagro C, Arroyo LA, et al. Pediatric parapneumonic empyema, Spain. Emerg Infect Dis. 2008;14:1390-1397.
7. Li ST, Tancredi DJ. Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine. Pediatrics. 2010;125:26-33.
8. Hendrickson DJ, Blumberg DA, Joad JP, et al. Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2008;27:1030-1032.
9. Le Monnier A, Carbonnelle E, Zahar JR, et al. Microbiological diagnosis of empyema in children: comparative evaluations by culture, polymerase chain reaction, and pneumococcal antigen detection in pleural fluids. Clin Infect Dis. 2006;42:1135-1140.
10. Vu-Thien H. Empyema: bacterial epidemiology and antibiotic resistance-in French + . Arch Pediatr. 2008;15(suppl 2):S81-S83.
11. Grupo de Trabajo de la Ponencia de Registro y Programa de Vacunas. Enfermedad invasora por Streptococcus pneumoniae. Implicación de la vacunación con la vacuna conjugada heptavalente. Madrid, Spain: Ministerio de Sanidad y Consumo; 2006.
12. Corless CE, Guiver M, Borrow R, Edwards-Jones V, et al. Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR. J Clin Microbiol. 2001;39:1553-1558. (Pubitemid 32275465)
13. Carvalho Mda G, Tondella ML, McCaustland K, et al. Evaluation and improvement of real-time PCR assays targeting lytA, ply, and psaA genes for detection of pneumococcal DNA. J Clin Microbiol. 2007;45:2460-2466. (Pubitemid 47295474)
14. Sanz JC, Culebras E, Ríos E, et al. Direct serogrouping of Streptococcus pneumoniae strains in clinical samples by use of a latex agglutination test. J Clin Microbiol. 2010;48:593-595.
15. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically-Seventh Edition: Approved Standard M7-A7. Wayne, PA: Clinical and Laboratory Standards Institute; 2006.
16. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Nineteenth Informational Supplement M100-S19. CLSI, Wayne, PA, USA, 2009.
17. Bekri H, Cohen R, Varon E, et al. Streptococcus pneumoniae serotypes involved in children with pleural empyemas in France in French + . Arch Pediatr. 2007;14:239-243. (Pubitemid 46357614)
18. Hsieh YC, Hsueh PR, Lu CY, et al. Clinical manifestations and molecular epidemiology of necrotizing pneumonia and empyema caused by Streptococcus pneumoniae in children in Taiwan. Clin Infect Dis. 2004;38:830-835.
19. Rees JH, Spencer DA, Parikh D, et al. Increase in incidence of childhood empyema in West Midlands, UK. Lancet. 1997;349:402. (Pubitemid 27077678)
20. Spencer DA, Iqbal SM, Hasan A, et al. Empyema thoracis is still increasing in UK children. BMJ. 2006;332:1333. (Pubitemid 44365394)
21. Byington CL, Spencer LY, Johnson TA, et al. An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations. Clin Infect Dis. 2002;34:434-440. (Pubitemid 34112262)
22. Tan TQ, Mason EO Jr, Wald ER, et al. Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae. Pediatrics. 2002;110(1 Pt 1):1-6. (Pubitemid 34742634)
23. Fenoll A, Granizo JJ, Aguilar L, et al. Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007. J Clin Microbiol. 2009;47:1012-1020.
24. Eltringham G, Kearns A, Freeman R, et al. Culture-negative childhood empyema is usually due to penicillin-sensitive Streptococcus pneumoniae capsular serotype 1. J Clin Microbiol. 2003;41:521-522. (Pubitemid 36098641)
25. Muñoz-Almagro C, Selva L, Ciruela P, et al. Serotype distribution including culture negative episodes of invasive pneumococcal disease (IPD) among children 5 years in Catalonia (Spain) 2007-2008. In: 7th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD); Tel Aviv, Israel; March 14-18, 2010.
26. Ciruela P, Cardeñosa M, Hernández S, et al. Clinical and epidemiological characteristics of Streptococcus pneumonia serotype 3 among children in Catalonia, Spain. In: 7th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD); Tel Aviv, Israel; March 14-18, 2010.
27. Isaacman DJ, McIntosh ED, Reinert RR. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int J Infect Dis. 2010;14:e197-e209.